Johannes J. van Lieshout, Wilbert A. Wesselink, Berend E. Westerhof
OpmizingPaentCareThrough) Management)of)Conflicts)of)Interest · Optimizing patient care through...
Transcript of OpmizingPaentCareThrough) Management)of)Conflicts)of)Interest · Optimizing patient care through...
Op#mizing Pa#ent Care Through Management of Conflicts of Interest
June 2, 2015
David Johnson, President & CEO,
Central Indiana Corporate Partnership and BioCrossroads
Thank You
Official Printer for Frameworx
@BioCrossroads
#patientinnovation #patientoutcomes #conflictofinterest
David Johnson, President & CEO,
Central Indiana Corporate Partnership and BioCrossroads
Optimizing patient care through management of conflicts of interest
Michael E Berend, MD Midwest Center for Joint Replacement
Joint Replacement Surgeons of Indiana Research Foundation
Rose Hulman Institute of Technology
Indianapolis, Indiana
Disclosure Research Funding, Intellectual
Property Transfer, Consulting
• Biomet, Stryker, DePuy, Wright
• St. Francis Hospital • National Science Foundation
• Orthalign
• Pacira
Interesting Hypothesis
“Scrutiny on physician-industry relationships are
handicapping innovation in
translational medicine and
marring the current
healthcare environment…”
affirm
How does patient care improve?
Ideas New Discovery
Clinical Trials
Collaboration Industry
Physicians
Training Education
Data
Value in Knowledge and Experience
• Experience: More joint replacements than any other group in Indiana ~ >34,000
• Largest clinical database in the state
• Local, regional, national, and international educators
• Research, teaching, and developers focused on clinical outcomes and cost reduction
Improving Patient Care with Industry Development Pathways
1. Basic Science and Clinic Research
2. Intellectual Property Transfer
3. Consulting
4. Independent IP development and
licensing and sale
Basic Science Research Funding
• Surgeon and Industry initiated
• Collaboration with Rose Hulman Institute of Technology & JRSI Foundation 501(c)(3)
Knee Replacement Technique 5mm resection
15mm resection
Small, Berend et al, JOA 2010
Component Mismatch - TKA
Berend et al, JOA 2010
Biomechanics of Alignment
neutral varus
Green, et al, JOA, 2002
Is there additional fruit? • 17 journal publications
• 22 conference presentations
• 37 nameable projects
• $486,309 in grants and gifts
• $414,460 in industry projects
• 42 undergraduate student research internships
• 12 masters student theses 18
• Student alumni currently in graduate school (MS and PhD): Florida (2), Clemson, Oxford, Illinois, Colorado (2), Cornell, Michigan, New Jersey, Purdue, Grace College (2).
• Alumni employees: Biomet, Zimmer, Depuy, Stryker, OrthoPediatrics, Paragon Medical, Cook, Boston Scientific, Covidien, Invacare, Beckman Coulter, MPS Precimed.
• MD students: IU Med (2) and Michigan State
video placeholder
Clinical Research ~ Patient Safety
Multicenter study comparing early complications (< 90 days) between TKA and UKA. ~3,000 knees.
Brown, et al, JOA, 2012
Is A Compartmentalist Approach Safer ?
Results : Total Complications
p < 0.001, Odds 2.8
252 of 2290
27 of 629
TKA 11.0%
UKA 4.3%
VS.
Brown, et al, JOA, 2012
Are the Patients More Satisfied?
Patient Satisfaction Residual Symptoms
Contributions: Publications
IP Transfer: Patent Assignment
Outpatient Joint Replacement Clinical Innovation ~ Pathways and Processes
Cost savings, early return to function and work, higher satisfaction
Medicine is Dynamic
• EMR • “Meaningful” use • SGR • Payment advisory board • Medicare reducMons • Regulatory “oversight”
Timeline of Arthroplasty Length of Stay
From Keith R Berend, MD, JIS, Inc
Outpatient Joint Replacement Center Development
Perspective on Scrutiny
Department of Justice
Additional Scrutiny The Indianapolis Star
November 12, 2007
Docs bristle at suggestion of kickbacks; Feds probe orthopedic surgeons' fees from artificial device makers
“Federal prosecutors call them bribes and kickbacks. Orthopedic surgeons call them legitimate consulting fees for their hard work and expertise.”
Physician Financial Transparency Reports
Management ~ Disclosure Patient Consent Form
End Result
www.mcjr.com
Thank You
Laura Lyons, Vice President of Clinical, Quality and Regulatory Affairs,
SonarMed, Inc.
Inventor, this is my “baby”
Early collaboraMon with Regulatory experts increases chance of success
! Inventors partner with a regulatory resource early in the process – Ensures they are documenMng the work being done so this can be
used in the regulatory submission process
– SomeMmes the path is easier or more difficult than the company originally thinks
– Provides the company with the valuable informaMon they need on cost of the regulatory process
56
Conflicts of Interest
Investor-‐It costs how much and takes how long??
Proper funding for the regulatory process ! Investors need clear communicaMon from the inventor or
company on the costs of the regulatory process – Company needs understanding and again partnering with regulatory
early on is essenMal
! Investors need to understand that the regulatory process changes subtly (or not so subtly) and they need to remain flexible – Regulatory bodies do not typically communicate or guarantee
Mmelines, and their Mmelines are not the same as the company anyway
57
Conflicts of Interest
! Take the Mme to find out what the user really wants – This is not always what the people closest to the product see
– Involve the clinicians who will use the product early and o^en
Clinical
58
Inventor/Company Needs Clear User Requirements
Start Up Company
59
It takes longer than you expect
! And that means you probably need more money than you think – Hiring seasoned execuMves is expensive but worthwhile and may shorten the process
! The work is rewarding – Though o^en Mmes it is daunMng (wear lots of hats) knowing you are bringing a product to market that will improve or save lives is extremely saMsfying
Anantha Shekhar, MD, PhD, Director,
Indiana Clinical and TranslaMonal Sciences InsMtute
Op#mizing Pa#ent Care Through Management of Conflicts of Interest
June 2, 2015
Thank You
Official Printer for Frameworx
@BioCrossroads
#patientinnovation #patientoutcomes #conflictofinterest